ArticlePulmonary circulation2024

IMPAHCT: A randomized phase 2b/3 study of inhaled imatinib for pulmonary arterial hypertension.

Hunter Gillies et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.